PHA CanadaMay 131 minSotatercept is now listed on Health Canada's websiteWe are pleased to announce that sotatercept, a new drug for patients diagnosed with pulmonary arterial hypertension (PAH), is now listed...
PHA CanadaMay 51 minDr. Jason Weatherald Discusses the Burden of PAH on the PHaware PodcastTune in to the latest episode of the PHaware podcast, where Dr. Jason Weatherald, a pulmonologist at the University of Alberta, delves...
PHA CanadaMar 261 minThe FDA has granted approval for the medication sotaterceptThe US Food and Drug Administration (FDA) has granted approval for the medication sotatercept, a significant milestone in the treatment...
PHA CanadaNov 26, 20221 minThe evolving landscape of pulmonary arterial hypertension clinical trialsClick here to read the article